Kidney function study of an investigational injection
Part of Hormones & metabolism clinical trials.
This study looks at how a new injection (HDM1005) is processed by the body in people with different levels of kidney function, including healthy volunteers. It aims to help understand dosing for people with kidney issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your weight must be at least 110 lbs (50 kg) if you're male, or 99 lbs (45 kg) if you're female.
- Your body mass index (BMI) must be between 19 and 35.
- You must have either normal kidney function or be diagnosed with moderate or severe chronic kidney disease.
- You cannot have a personal or family history of a certain type of thyroid cancer or a rare endocrine condition.
- You must be willing to sign an informed consent form and attend all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a new medicine, HDM1005, may change the way the body absorbs or processes some common medications like metformin, atorvastatin, warfarin, and digoxin. It may help doctors understand if HDM1005 can be taken safely with other drugs.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests an investigational injection called UBT251 for people with chronic kidney disease who are overweight. It aims to see if it can reduce protein in the urine and help protect kidney function.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study is testing a new injectable medicine (HRS-4729) to see how the body processes it in people with healthy kidneys and in those with kidney problems. If you join, you will receive a single dose and have your blood and urine checked over time to measure the drug levels.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.